Voyageur Pharmaceuticals Ltd (VM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 05-2024 | 02-2024 | 11-2023 | 08-2023 | 05-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 0 | 1 | 1 | 1 |
| Accounts receivable | -9 | 18 | -9 | 18 | -6 |
| Other Working Capital | 127 | 19 | 254 | 81 | -84 |
| Other Operating Activity | -308 | -221 | -215 | -167 | -393 |
| Operating Cash Flow | $-189 | $-183 | $30 | $-67 | $-483 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -38 | -38 | -33 | -55 | -45 |
| Investing Cash Flow | $-38 | $-38 | $-33 | $-55 | $-45 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -6 | 494 | 4 | 0 | 0 |
| Other Financing Activity | -4 | -25 | 0 | 0 | 0 |
| Financing Cash Flow | $-9 | $468 | $4 | $0 | $0 |
| Beginning Cash Position | 250 | 2 | 2 | 124 | 652 |
| End Cash Position | 13 | 250 | 2 | 2 | 124 |
| Net Cash Flow | $-237 | $248 | $0 | $-122 | $-528 |
| Free Cash Flow | |||||
| Operating Cash Flow | -189 | -183 | 30 | -67 | -483 |
| Free Cash Flow | -189 | -183 | 30 | -67 | -483 |